NO20055882L - Farmasoytiske formuleringer omfattende amoksicillin og klavulanat - Google Patents

Farmasoytiske formuleringer omfattende amoksicillin og klavulanat

Info

Publication number: NO20055882L
Authority: NO; Norway
Prior art keywords: clavulanate; amoxicillin; pharmaceutical formulations; formulations; reconstitution
Prior art date: 2003-06-16

Application number

NO20055882A

Other languages

English (en)

Norwegian (no)

Inventor

Jill Tracy Rickman

Michael Gale Ramsey

Original Assignee

Glaxo Group Ltd

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2003-06-16

Filing date

2005-12-12

Publication date

2005-12-28

2003-06-16 Priority claimed from GBGB0313913.6A external-priority patent/GB0313913D0/en

2005-12-12 Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd

2005-12-28 Publication of NO20055882L publication Critical patent/NO20055882L/no

Links

HZZVJAQRINQKSD-UHFFFAOYSA-N Clavulanic acid Natural products OC(=O)C1C(=CCO)OC2CC(=O)N21 HZZVJAQRINQKSD-UHFFFAOYSA-N 0.000 title abstract 2
LSQZJLSUYDQPKJ-NJBDSQKTSA-N amoxicillin Chemical compound C1([C@@H](N)C(=O)N[C@H]2[C@H]3SC([C@@H](N3C2=O)C(O)=O)(C)C)=CC=C(O)C=C1 LSQZJLSUYDQPKJ-NJBDSQKTSA-N 0.000 title abstract 2
229960003022 amoxicillin Drugs 0.000 title abstract 2
229940090805 clavulanate Drugs 0.000 title abstract 2
HZZVJAQRINQKSD-PBFISZAISA-N clavulanic acid Chemical compound OC(=O)[C@H]1C(=C/CO)/O[C@@H]2CC(=O)N21 HZZVJAQRINQKSD-PBFISZAISA-N 0.000 title abstract 2
LSQZJLSUYDQPKJ-UHFFFAOYSA-N p-Hydroxyampicillin Natural products O=C1N2C(C(O)=O)C(C)(C)SC2C1NC(=O)C(N)C1=CC=C(O)C=C1 LSQZJLSUYDQPKJ-UHFFFAOYSA-N 0.000 title abstract 2
239000008194 pharmaceutical composition Substances 0.000 title 1
DPXJVFZANSGRMM-UHFFFAOYSA-N acetic acid;2,3,4,5,6-pentahydroxyhexanal;sodium Chemical compound [Na].CC(O)=O.OCC(O)C(O)C(O)C(O)C=O DPXJVFZANSGRMM-UHFFFAOYSA-N 0.000 abstract 1
239000007900 aqueous suspension Substances 0.000 abstract 1
229920003123 carboxymethyl cellulose sodium Polymers 0.000 abstract 1
229940063834 carboxymethylcellulose sodium Drugs 0.000 abstract 1
238000009472 formulation Methods 0.000 abstract 1
239000000203 mixture Substances 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
- A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/42—Oxazoles
- A61K31/424—Oxazoles condensed with heterocyclic ring systems, e.g. clavulanic acid
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/425—Thiazoles
- A61K31/429—Thiazoles condensed with heterocyclic ring systems
- A61K31/43—Compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula, e.g. penicillins, penems
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

Health & Medical Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Veterinary Medicine (AREA)
Chemical & Material Sciences (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Animal Behavior & Ethology (AREA)
Life Sciences & Earth Sciences (AREA)
Epidemiology (AREA)
Organic Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Oncology (AREA)
Communicable Diseases (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicinal Preparation (AREA)

NO20055882A 2003-06-16 2005-12-12 Farmasoytiske formuleringer omfattende amoksicillin og klavulanat NO20055882L (no)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
US47876903P	2003-06-16	2003-06-16
GBGB0313913.6A GB0313913D0 (en)	2003-06-16	2003-06-16	New use
PCT/EP2004/006551 WO2004110441A1 (en)	2003-06-16	2004-06-15	Pharmaceutical formulations comprising amoxicillin and clavulanate

Publications (1)

Publication Number	Publication Date
NO20055882L true NO20055882L (no)	2005-12-28

Family

ID=33420899

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
NO20055882A NO20055882L (no)	2003-06-16	2005-12-12	Farmasoytiske formuleringer omfattende amoksicillin og klavulanat

Country Status (13)

Country	Link
EP (1)	EP1491195A1 (pt)
JP (1)	JP2006527726A (pt)
KR (1)	KR20060010838A (pt)
AU (1)	AU2004246811A1 (pt)
BR (1)	BRPI0411524A (pt)
CA (1)	CA2529102A1 (pt)
CO (1)	CO5640085A2 (pt)
IL (1)	IL172096A0 (pt)
MA (1)	MA27850A1 (pt)
MX (1)	MXPA05013433A (pt)
NO (1)	NO20055882L (pt)
RU (1)	RU2343931C2 (pt)
WO (1)	WO2004110441A1 (pt)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DE102007002924A1 (de) *	2007-01-19	2008-07-24	Bayer Healthcare Ag	ß-Lactam-haltige Formulierungen mit erhöhter Stabilität in wässriger Lösung
KR20140117523A (ko) *	2012-01-10	2014-10-07	마이클 스펙터	아목시실린 및 클라불란산 칼륨의 소아용 경구 현탁 제형 및 이를 사용하기 위한 방법
CN114668724B (zh) *	2020-12-24	2023-08-22	鲁南制药集团股份有限公司	一种阿莫西林克拉维酸钾干混悬剂及其制备方法
CN114886893B (zh) *	2021-07-30	2023-09-29	江苏恒丰强生物技术有限公司	一种复方阿莫西林粉及其制备方法
CN116327760A (zh) *	2022-12-26	2023-06-27	南京臣功制药股份有限公司	一种阿莫西林克拉维酸钾缓释干混悬剂及其制备方法
WO2025141532A1 (en) *	2023-12-29	2025-07-03	Aodh Lifesciences Private Limited	Amoxicillin clavulanate nasal spray

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
CA2280857A1 (en) *	1997-02-14	1998-08-20	Smithkline Beecham Laboratoires Pharmaceutiques	Pharmaceutical formulations comprising amoxocyllin and clavulanate
GB9815532D0 (en) *	1998-07-17	1998-09-16	Lek Pharmaceutical & Cvhemical	Pharmaceutical suspension formulation
US6177421B1 (en) *	1999-05-04	2001-01-23	Fuisz International Ltd.	Amoxicillin and clavulanate composition
WO2001013883A1 (en) *	1999-08-20	2001-03-01	Smithkline Beecham Laboratoires Pharmaceutiques S.A.S.	Pharmaceutical formulation comprising amoxycillin and clavulanate

2004
- 2004-06-15 CA CA002529102A patent/CA2529102A1/en not_active Abandoned
- 2004-06-15 WO PCT/EP2004/006551 patent/WO2004110441A1/en not_active Ceased
- 2004-06-15 AU AU2004246811A patent/AU2004246811A1/en not_active Abandoned
- 2004-06-15 JP JP2006515979A patent/JP2006527726A/ja active Pending
- 2004-06-15 RU RU2005138127/15A patent/RU2343931C2/ru not_active IP Right Cessation
- 2004-06-15 BR BRPI0411524-4A patent/BRPI0411524A/pt not_active IP Right Cessation
- 2004-06-15 MX MXPA05013433A patent/MXPA05013433A/es not_active Application Discontinuation
- 2004-06-15 EP EP20040076764 patent/EP1491195A1/en not_active Ceased
- 2004-06-15 KR KR1020057024090A patent/KR20060010838A/ko not_active Withdrawn
2005
- 2005-11-22 IL IL172096A patent/IL172096A0/en unknown
- 2005-12-09 MA MA28647A patent/MA27850A1/fr unknown
- 2005-12-12 NO NO20055882A patent/NO20055882L/no not_active Application Discontinuation
- 2005-12-12 CO CO05125090A patent/CO5640085A2/es not_active Application Discontinuation

Also Published As

Publication number	Publication date
KR20060010838A (ko)	2006-02-02
RU2005138127A (ru)	2006-07-27
MXPA05013433A (es)	2006-03-09
IL172096A0 (en)	2009-02-11
WO2004110441A1 (en)	2004-12-23
AU2004246811A1 (en)	2004-12-23
JP2006527726A (ja)	2006-12-07
CA2529102A1 (en)	2004-12-23
RU2343931C2 (ru)	2009-01-20
BRPI0411524A (pt)	2006-08-01
WO2004110441A8 (en)	2005-03-17
MA27850A1 (fr)	2006-04-03
EP1491195A1 (en)	2004-12-29
CO5640085A2 (es)	2006-05-31

Similar Documents

Publication	Publication Date	Title
NO20024891L (no)	2002-12-05	Farmasöytiske sammensetninger
DK1206467T3 (da)	2004-04-26	N-heterocykliske derivater som NOS-inhibitorer
HK1049165A1 (zh)	2003-05-02	循环β-氨基酸衍生物作为质基金属蛋白酶及TNF-α的抑制剂
NO20075693L (no)	2008-02-07	Modulerende forbindelser av indolamin-2,3-dioksygenase og fremgangsmater for anvendelse av samme
ECSP066662A (es)	2006-10-25	Preparación farmacéutica que comprende un anticuerpo contra el receptor egf
DK1317419T3 (da)	2009-06-15	Cyanophenoxycarboxylsyre-forbindelser og sammensætninger til at levere aktive midler
NO20030374L (no)	2003-01-24	Syklopentanoindoler, preparater som inneholder slike forbindelser og behandlingsfremgangsmåter
NO20052887D0 (no)	2005-06-14	Pyridazinonderivater som GSK-3Beta inhibitorer.
ATE485835T1 (de)	2010-11-15	Antikörper enthaltende pharmazeutische lösungen
WO2004033632A3 (en)	2004-07-15	Hydantoin derivatives as inhibitors of matrix metalloproteinases and/or tnf-alpha converting enzyme (tace)
NO20081942L (no)	2008-04-23	Karbamoylbenzotriazolderivater som inhibitorer av lipaser og fosfolipaser
ATE303149T1 (de)	2005-09-15	Orale pharmazeutische zusammensetzung aus cefpodoxim-proxetil
NO20022201L (no)	2002-05-08	Lösninger inneholdende Epinastin
DK1517890T3 (da)	2008-11-10	Kationisk substituerede diphenylazetidinoner, fremgangsmåde til deres fremstilling, lægemidler indeholdende disse forbindelser og deres anvendelse
TR200201174T2 (tr)	2002-08-21	Florokinolon antibiyotik ilacı ve iksantan zamkı içeren farmasötik bileşimler.
NO20053042L (no)	2005-06-21	Anvendelse av spongosin (2-metoksyadenosin) for behandling av smerte, saerlig hyperalgesi.
GB0308201D0 (en)	2003-05-14	Novel compounds
BR0313385A (pt)	2005-06-14	Derivados de pirimidina-2,4-diona como inibidores de metaloproteinase da matriz
EA201070194A1 (ru)	2010-06-30	Стабильная жидкая фармацевтическая композиция на основе тразодона
NO20055631L (no)	2005-11-29	Doseringsform inneholdende pantoprazol som aktiv ingrediens
NO20055882L (no)	2005-12-28	Farmasoytiske formuleringer omfattende amoksicillin og klavulanat
NO20073071L (no)	2007-06-15	Benzotiazolformuleringer og anvendelse av disse
AU2003249535A1 (en)	2004-02-25	1,6-fused uracil derivatives as matrix metalloproteinase inhibitors
TW200509990A (en)	2005-03-16	Pharmaceutical formulations
AU2003258630A1 (en)	2004-03-11	Pyrimidine derivatives as selective cox-2 inhibitors

Legal Events

Date	Code	Title	Description
2011-01-31	FC2A	Withdrawal, rejection or dismissal of laid open patent application